Skip to main content

Table 1 DNA markers used for comparison of genetic alterations in estrogen receptor-negative cells and estrogen receptor-positive cells

From: Cell clusters overlying focally disrupted mammary myoepithelial cell layers and adjacent cells within the same duct display different immunohistochemical and genetic features: implications for tumor progression and invasion

Marker

Name

Chromosomal location

Harbored gene

Size (base pairs)

1

D3S1300

3p21.1–p14.2

FHIT

217–241

2

D3S1481

3p14.2

FHIT

104

3

D3S1581

3p21.2–p14.2

FHIT

78–102

4

D11S902

11p15–p13

?

145–163

5

D11S904

11p14–p13

Wilms' tumor 1

185–201

6

D11S907

11p13

Wilms' tumor 1

163–173

7

D11S914

11p13–p12

Wilms' tumor 1

275–285

8

D13S119

13q14.3–q22

?

124–140

9

D13S173

13q32–q34

?

166–178

10

D13S219

13q12.3–q13

?

117–127

11

D13S263

13q14.1–q14.2

?

145–165

12

D16S518

16q23.1–q24.2

CDH 1 (adjacent to it)

272–290

13

D16S402

16q24.2

CDH 1 (adjacent to it)

161–187

14

D17S791

17q

BRCA 1

165–199

15

TP53

17p13

P53

104

  1. FHIT, fragile histidine triad.